Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01327898 · ClinicalTrials.gov registry record · Phase 2
Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
A Phase 2 study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 515
- Enrollment target
NCT01327898: Completed Phase 2 study, sponsored by Nova Southeastern University.
NCT01327898 is a Phase 2 study that has completed, run by Nova Southeastern University. The registered enrollment target is 515 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (287% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01327898, a Phase 2 study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 515 participants
- Enrollment target
Study Summary
The specific aims of the 5-year study are to: 1) describe the nature and extent of substance use and sexual risk behaviors in a sample of 500 sexually active, substance using, not-in-treatment men who have sex with men (MSM) in urban South Florida (Miami/Ft. Lauderdale); 2) identify the independent covariates of baseline substance abuse and sexual risks; 3) evaluate, through random assignment of participants, the relative effectiveness of two intervention conditions in reducing sexual risks and substance use, as measured at 3-, 6-, and 12-month follow-up assessments: a) an innovative five-session risk reduction intervention derived from psychological empowerment theory titled Project GOAL; and, b) an enhanced community standard-of-care HIV counseling Comparison Condition.
Interventions
- BEHAVIORAL empowerment theory-based small group discussion
- BEHAVIORAL individual resilience counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 515 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
What the finished NCT01327898 record still lists
NCT01327898 is an interventional study that assigns participants to a tested intervention. The registered 515 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (287% higher).
The record links to 0 conditions, and to 2 interventions - of which empowerment theory-based small group discussion is the first listed.
NCT01327898 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01327898 about?
NCT01327898 is a clinical study titled "Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)". The specific aims of the 5-year study are to: 1) describe the nature and extent of substance use and sexual risk behaviors in a sample of 500 sexually active, substance using, not-in-treatment men who have sex with men (MSM) in urban South Florida (Miami/Ft. Lauderdale); 2) identify the independent ...
What is the current status of trial NCT01327898?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 515 participants. The study started on 2008-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01327898?
The interventions under investigation include: empowerment theory-based small group discussion (BEHAVIORAL), individual resilience counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01327898?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01327898's enrollment target sits among peer trials
515 67th of 2000 higher than 1,934 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia